Haselmeier develops a brand new pen injector platform named i-pen.

The BerliPen® areo 1 – a first application of the i-pen platform – is launched by Berlin-Chemie in Germany, as a reusable pen for insulin therapy. This pen offers state-of-the-art design and function as well as a simple manual drug delivery experience for active and practiced patients.